Abstract:Clinical oncology is currently experiencing a technology bottleneck due to the expeditious evolution of therapy defiance in tumors. Although drugs used in chemotherapy work for a sort of cell death with potential clinical application, the effectiveness of chemotherapy-inducing drugs is subject to several endogenous conditions when used alone, necessitating the urgent need for controlled mechanisms. A tumor-targeted drug delivery therapy using Li-Al (M+/M3+)-based layered double hydroxide (LDHs) family has been proposed with the general chemical formula [M+1-x M3+x (OH)]2x+[(Am-)2x/m. n(H2O)]2x-, which is fully biodegradable and works in connection with the therapeutic interaction between LDH nanocarriers and anticancerous doxorubicin (DOX). Compositional variation of Li and Al in LDHs has been used as a nanoplatform, which provides a functional balance between circulation lifetime, drug loading capacity, encapsulation efficiency, and tumor-specific uptake to act as self-regulatory therapeutic cargo to be released intracellularly. First-principle analyses based on DFT have been employed to investigate the interaction of bonding and electronic structure of LDH with DOX and assess its capability and potential for a superior drug carrier. Following the internalization into cancer cells, nanoformulations are carried to the nucleus via lysosomes, and the mechanistic pathways have been revealed. Additionally, in vitro along with in vivo therapeutic assessments on melanoma-bearing mice show a dimensional effect of nanoformulation for better biocompatibility and excellent synergetic anticancer activity. Further, the severe toxic consequences associated with traditional chemotherapy have been eradicated by using injectable hydrogel placed just beneath the tumor site, and regulated release of the drug has been confirmed through protein expression applying various markers. However, Li-Al-based LDH nanocarriers open up new design options for multifunctional nanomedicine, which has intriguing potential for use in cancer treatment through sustained drug delivery.

Layered Double Hydroxide Nanoparticles for Efficient Gene Delivery for Cancer Treatment

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Ph-Responsive Polydopamine Nanoparticles for Photothermally Promoted Gene Delivery

Ultrasound-Enhanced Reactive Oxygen Species Responsive Charge-Reversal Polymeric Nanocarriers for Efficient Pancreatic Cancer Gene Delivery.

Controlled preparation of layered double hydroxide nanoparticles and their application as gene delivery vehicles

Functionalized Layered Double Hydroxide Nanoparticles Conjugated with Disulfide-Linked Polycation Brushes for Advanced Gene Delivery

Layered double hydroxide nanoparticles in gene and drug delivery.

A Ph-Sensitive Multifunctional Gene Carrier Assembled Via Layer-By-Layer Technique for Efficient Gene Delivery

Delivery of Surface-Mediated Non-Viral Gene Nanoparticles from Ultrathin Layer-by-layer Multilayers

Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery.

Doxorubicin-Intercalated Li-Al-Based LDHs as Potential Drug Delivery Nanovehicle with pH-Responsive Therapeutic Cargo for Tumor Treatment

Self-assembled CaP-based Hybrid Nanoparticles to Enhance Gene Transfection Efficiency in Vitro and in Vivo: Beneficial Utilization of PEGylated Bisphosphate and Nucleus Locating Signal

A Cancer Cell Membrane Coated Nanoparticles-Based Gene Delivery System for Enhancing Cancer Therapy

Bio-LDH nanohybrid for gene therapy

Alginate/Caco3 Hybrid Nanoparticles For Efficient Codelivery Of Antitumor Gene And Drug

Surface-mediated Non-Viral Gene Nanoparticles Delivery from Ultrathin Layer-by-layer Multilayers

Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors

Facile Formation of PAMAM Dendrimer Nanoclusters for Enhanced Gene Delivery and Cancer Gene Therapy

Light Controlled Self‐escape Capability of Non‐cationic Carbon Nitride‐based Nanosheets in Lysosomes for Hepatocellular Carcinoma Targeting Stimulus‐responsive Gene Delivery

Highly Water-Dispersible PCN Nanosheets As Light-Controlled Lysosome Self-Promoting Escape Type Non-Cationic Gene Carriers for Tumor Therapy.

Well water-dispersible PCN nanosheets as light-controlled lysosome self-promoting escape type non-cationic gene carriers for tumor therapy